The company has an in-house processing lab to formulate new cannabinoid profiles with different THC to CBD ratios, and work with patients and dispensaries like Greenhouse to determine which strains are most effective for specific symptoms. Much of the information available about the effectiveness of strains comes from patient testimony, Golderberg said, as clinical studies have been limited because of cannabis’ illegality in the past.